Bedrijfsvoering Lonza Group AG

LONN

CH0013841017

Biotechnologie & Medisch Onderzoek

Beurs gesloten - Swiss Exchange Andere beurzen 17:31:01 24-01-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
591,00 ^CHF	+1,34%		+6,60%	+10,30%

14/01	Lonza Group AG Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 11:15 AM
13/01	Iconovo AB (Publ) en Lonza gaan samenwerken aan de ontwikkeling van een intranasaal biologisch geneesmiddel	CI

Uitvoerend comité: Lonza Group AG

Bedrijfsleider

Beklede functiesVan

Wolfgang Wienand

53 jaar

Chief Executive Officer

01-07-2024

Philippe Deecke

53 jaar

Director of Finance/CFO

01-12-2021

Maria Nunez

56 jaar

Chief Operating Officer

01-08-2022

Lyle Wheeler

Investor Relations Contact

Ulrike Käppler

Human Resources Officer

01-01-2024

Samenstelling van de raad van bestuur: Lonza Group AG

Directeur

RadenVan

R. Jean-Marc Sidney Huët

56 jaar

Audit Committee	25-04-2019
Compensation Committee	25-04-2019

Christoph Mäder

65 jaar

Audit Committee	30-04-2021
Compensation Committee Chair	26-04-2016
Nominating Committee Chair	26-04-2016
Compensation Committee	26-04-2019

Jürgen B. Steinemann

67 jaar

Compensation Committee	29-10-2014
Nominating Committee	29-10-2014
Audit Committee	21-02-2017
Nominating Committee Chair	21-02-2017

Marion Helmes

59 jaar

Audit Committee	05-05-2022
Audit Committee Chair	19-04-2018
Compensation Committee

Angelica Kohlmann

65 jaar

Compensation Committee	04-05-2018
Nominating Committee	04-05-2018

Barbara Richmond

64 jaar

Audit Committee Chair

16-04-2014

Olivier Verscheure

53 jaar

Director/Board Member	04-05-2018
Independent Dir/Board Member	04-05-2018

Roger Nitsch

64 jaar

Director/Board Member	01-05-2022
Independent Dir/Board Member	01-05-2022

Recente benoemingen: Lonza Group AG

Lonza Group benoemt nieuwe CEO	03-07-24	MT
Lonza Group AG kondigt wijzigingen aan in CEO	02-07-24	CI
Nieuwe CEO Lonza Group neemt rol over	01-07-24	MT
Lonza Group AG kondigt wijzigingen in de Raad van Bestuur aan	10-05-24	CI
Lonza Group benoemt nieuwe CEO; wil handelsstop opheffen	02-04-24	MT
Siegfried CEO stapt op; financieel directeur wordt interim CEO	02-04-24	MT
Lonza Group neemt Siegfried's CEO over	02-04-24	MT

Meer nieuws

Voormalige zaakvoerders en bestuurders: Lonza Group AG

Insider

Beklede functies

VanTot

Albert Baehny

Director/Board Member	25-04-2017	04-05-2018
Chief Executive Officer	30-09-2023	01-07-2024
Chairman	04-05-2018	08-05-2024
Independent Dir/Board Member	01-11-2020	30-09-2023

Pierre-Alain Ruffieux

Chief Executive Officer

01-11-2020

30-09-2023

Caroline Barth

Human Resources Officer

01-04-2020

01-04-2023

Stefan Stoffel

Chief Operating Officer	01-03-2019	01-08-2022
Corporate Officer/Principal	01-01-2007	01-03-2019

Werner J. Bauer

Director/Board Member	09-04-2013	01-01-2022
Independent Dir/Board Member	09-04-2013	01-01-2022

Rodolfo Savitzky

Director of Finance/CFO

01-10-2016

01-12-2021

Tanya Hayden

Corporate Officer/Principal

01-04-2018

01-06-2021

Sanna Fowler

Public Communications Contact

01-03-2021

Sven Abend

Corporate Officer/Principal

01-07-2014

30-06-2020

Kristin Koehler

Investor Relations Contact

01-06-2020

Moncef Slaoui

Director/Board Member	01-04-2020	18-05-2020
Independent Dir/Board Member	01-04-2020	18-05-2020

Dorothée Anna Deuring

Director/Board Member	28-04-2020	-
Independent Dir/Board Member	28-04-2020	-

Patrick Aebischer

Director/Board Member	01-03-2008	01-04-2020
Independent Dir/Board Member	20-05-2010	01-04-2020
Corporate Officer/Principal	09-04-2009	20-05-2010

Margot A. Scheltema

Director/Board Member	01-04-2012	01-04-2020
Independent Dir/Board Member	01-04-2012	01-04-2020

Scott B. Waldman

Corporate Officer/Principal

01-04-2010

01-02-2020

Marc Funk

Chief Executive Officer	01-03-2019	12-11-2019
General Counsel	01-01-2009	-
Corporate Officer/Principal	31-12-2014	01-03-2019
Corporate Secretary	01-01-2009	31-12-2014

Aurélie Dalbiez

Human Resources Officer

01-09-2020

Antonio Trius

Director/Board Member

01-04-2013

01-04-2019

Fridtjof Helemann

Human Resources Officer

01-06-2016

31-03-2019

Richard Ridinger

Chief Executive Officer

01-05-2012

28-02-2019

Jean-Daniel Gerber

Director/Board Member	01-04-2011	04-05-2018
Independent Dir/Board Member	01-04-2011	04-05-2018

Rolf Soiron

Chairman	11-04-2005	04-05-2018
Independent Dir/Board Member	11-04-2005	04-05-2018
President	11-04-2005	02-05-2012

Jamie Hawkes

Corporate Officer/Principal

20-01-2016

01-01-2018

Thomas Ebeling

Director/Board Member	01-03-2013	01-03-2017
Independent Dir/Board Member	01-03-2013	01-03-2017

Toralf Haag

Director of Finance/CFO

11-10-2011

01-10-2016

Frank Delano Kicklighter

Corporate Officer/Principal

30-03-2016

Stephan Kutzer

Corporate Officer/Principal

20-05-2010

01-07-2014

Peter Wilden

Director/Board Member	20-05-2010	16-04-2014
Corporate Officer/Principal	09-04-2009	20-05-2010

Richard Sykes

Director/Board Member	20-05-2010	09-04-2013
Corporate Officer/Principal	09-04-2009	20-05-2010

Gerhard Mayr

Director/Board Member	20-05-2010	09-04-2013
Corporate Officer/Principal	09-04-2009	20-05-2010

Hans Jörg Reinhardt

Director/Board Member

01-04-2012

09-04-2013

Antonio Trius Oliva

Director/Board Member	01-04-2013	-
Independent Dir/Board Member	01-04-2013	-

Uwe H. Böhlke

Human Resources Officer

20-05-2010

01-01-2013

Lukas Utiger

Corporate Officer/Principal

20-05-2010

01-02-2013

Jeanne A. Thoma

Corporate Officer/Principal

01-10-2011

01-02-2013

Harry Boot

Corporate Officer/Principal

06-06-2011

01-06-2012

Julia Higgins

Director/Board Member	20-05-2010	01-04-2012
Corporate Officer/Principal	09-04-2009	20-05-2010

Stefan Borgas

Chief Executive Officer

01-06-2004

25-01-2012

Anja Fiedler

Corporate Officer/Principal

20-05-2010

01-06-2010

Frits van Dijk

Director/Board Member	31-03-2010	31-03-2010
Corporate Officer/Principal	09-04-2009	-

Alexandre Pasini

Public Communications Contact

29-07-2009

06-09-2009

Andreas Wirth

Corporate Officer/Principal

01-08-2005

01-09-2008

Beat In-Albon

Corporate Officer/Principal

01-01-2006

01-01-2007

Roland Waibel

Comptroller/Controller/Auditor	01-01-2006	01-01-2006
Director of Finance/CFO	01-01-2006	01-01-2006

Markus Gemuend

Chief Executive Officer

01-02-2002

01-06-2004

Rupert Gasser

Corporate Officer/Principal

01-01-1999

01-01-2004

Dirk Oehlers

Investor Relations Contact

01-11-2002

Sergio Marchionne

Chairman	01-10-2001	01-01-2002
President	-	-

Renè Dirren

Director/Board Member	11-07-2011	-
Corporate Officer/Principal	08-11-2010	11-07-2011

Alessandro Gianni Baldi

Corporate Officer/Principal

01-01-1999

Petros Kalantzis

Director/Board Member

01-01-1990

Mário Luiz Lorencatto

Corporate Officer/Principal

Richard D. Ditoro

Corporate Officer/Principal

Rosario Valido

Corporate Officer/Principal

Ian Nicholson

Corporate Officer/Principal

Michael Frizberg

Public Communications Contact

09-04-2009

Theodore G. Johnson

Corporate Officer/Principal

Constance Ward

Public Communications Contact

Wolfgang Kintzel

Corporate Officer/Principal

Titus Kretzschmar

Chief Tech/Sci/R&D Officer

Ken Morgan

Corporate Officer/Principal

Ahmed Tafesh

Corporate Officer/Principal

Bernard Mach

Director/Board Member

Diane Bitzel

Chief Tech/Sci/R&D Officer

Eugen Katzenstein

Corporate Officer/Principal

Dominik Werner

Public Communications Contact

20-05-2010

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	11
Vrouw	3

Waarvan leden van het uitvoerend comité

Man	4
Vrouw	1

Waarvan bestuurders

Man	7
Vrouw	1

ESG MSCI

AAA

ESG

Milieu

Sociaal

Bedrijfsvoering

Controverse

Lonza Group AG is een van de wereldleiders in de ontwikkeling, productie en marketing van chemische producten. De netto-omzet is als volgt over de product- en dienstenfamilie verdeeld - biofarmaceutica (55,4%): exclusieve syntheses, microbiologische fermentatieproducten, celculturen van zoogdieren, enz; - capsules en doseeroplossingen voor biofarmaceutica, geneesmiddelen en voedingsproducten (17,3%). Daarnaast biedt de groep voedingsingrediënten; - kleine molecule geneesmiddelsubstanties (13,4%); - technologieën en platforms voor productieprocessen en productie van cel- en gentherapieën (10,4%); - overige (3,5%). De netto-omzet is geografisch als volgt verdeeld: Zwitserland (17,4%), Europa (31,7%), de Verenigde Staten (31,8%), Noord- en Zuid-Amerika (3,2%), Japan (8,1%), Azië (7,5%) en overige (0,3%).

Werknemers

17.834

Sector

Biotechnologie & Medisch Onderzoek

Agenda

29-01-2025 - Q4 2024 Cijferpublicaties

Meer informatie over het bedrijf